Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 27
Filtrer
1.
Sci Rep ; 14(1): 4885, 2024 02 28.
Article de Anglais | MEDLINE | ID: mdl-38418448

RÉSUMÉ

Early diagnosis and following management are important determinants of the prognosis of multiple myeloma (MM). However, screening for MM is not routinely performed because it is rare disease. In this study, we evaluated the association of prior disease condition and socioeconomic status (SES) with MM diagnosis and developed a simple predictive model that can identify patients at high risk of developing MM who may need screening using nationwide database from South Korea. According to multivariate logistic regression analysis, eight prior disease conditions and SES before diagnosis were shown to be predictors of MM development and selected for score development. Total prediction scores were categorized into four groups: patients without any risk (≤ 0) intermediate-1 (0.5-9), intermediate-2 (9-14), and high risk (> 14). The odds ratios for developing MM in the intermediate-1, intermediate-2, and high-risk groups were 1.29, 3.07, and 4.62, respectively. The association of prior disease conditions and SES with MM diagnosis were demonstrated and the simple scoring system to predict the MM risk was developed. This scoring system is also provided by web-based application and could be a useful tool to support clinicians in identifying potential candidates for MM screening.


Sujet(s)
Myélome multiple , Humains , Études de cohortes , Myélome multiple/diagnostic , Myélome multiple/épidémiologie , Classe sociale , Facteurs de risque , Appréciation des risques
2.
Respir Res ; 22(1): 131, 2021 Apr 28.
Article de Anglais | MEDLINE | ID: mdl-33910566

RÉSUMÉ

BACKGROUND: Limited data are available on practical predictors of successful de-cannulation among the patients who undergo tracheostomies. We evaluated factors associated with failed de-cannulations to develop a prediction model that could be easily be used at the time of weaning from MV. METHODS: In a retrospective cohort of 346 tracheostomised patients managed by a standardized de-cannulation program, multivariable logistic regression analysis identified variables that were independently associated with failed de-cannulation. Based on the logistic regression analysis, the new predictive scoring system for successful de-cannulation, referred to as the DECAN score, was developed and then internally validated. RESULTS: The model included age > 67 years, body mass index < 22 kg/m2, underlying malignancy, non-respiratory causes of mechanical ventilation (MV), presence of neurologic disease, vasopressor requirement, and presence of post-tracheostomy pneumonia, presence of delirium. The DECAN score was associated with good calibration (goodness-of-fit, 0.6477) and discrimination outcomes (area under the receiver operating characteristic curve 0.890, 95% CI 0.853-0.921). The optimal cut-off point for the DECAN score for the prediction of the successful de-cannulation was ≤ 5 points, and was associated with the specificities of 84.6% (95% CI 77.7-90.0) and sensitivities of 80.2% (95% CI 73.9-85.5). CONCLUSIONS: The DECAN score for tracheostomised patients who are successfully weaned from prolonged MV can be computed at the time of weaning to assess the probability of de-cannulation based on readily available variables.


Sujet(s)
Drains thoraciques , Techniques d'aide à la décision , Ablation de dispositif , Ventilation artificielle , Trachéostomie/instrumentation , Sevrage de la ventilation mécanique , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Ablation de dispositif/effets indésirables , Conception d'appareillage , Femelle , Humains , Unités de soins intensifs , Mâle , Adulte d'âge moyen , Valeur prédictive des tests , Ventilation artificielle/effets indésirables , Études rétrospectives , Appréciation des risques , Facteurs de risque , Trachéostomie/effets indésirables , Résultat thérapeutique , Sevrage de la ventilation mécanique/effets indésirables
3.
Gastroenterol Res Pract ; 2020: 8129525, 2020.
Article de Anglais | MEDLINE | ID: mdl-32328099

RÉSUMÉ

OBJECTIVE: Studies comparing magnetic resonance enterography (MRE) and capsule endoscopy (CE) for the assessment of small bowel (SB) Crohn's disease (CD) are scarce in Korea. In addition, there is no Korean experience of patency capsule (PC) examination prior to CE. The primary aim of this study was to compare diagnostic yields of MRE and CE for the assessment of SB CD. Secondary objectives were to compare the detection rate of proximal SB lesions by each modality in the Montreal classification and evaluate the safety and feasibility of PC in Korean CD patients. METHODS: MRE was performed as the first examination to assess SB CD. PC examination and CE were then performed. Diagnostic yields of active SB disease by MRE and CE were then analyzed. RESULTS: Disintegration of the patency capsule was shown in 5 patients out of 26 patients, who did not undergo CE. These 5 patients were accounted as negative CE findings. Overall, MRE and CE detected 80.8% and 65.4% of active SB lesions of CD in 26 patients, respectively (P = 0.212). MRE and CE detected 0% (0/26) and 19.2% (5/26) (P = 0.051) of jejunal lesions, 30.8% (8/26) and 42.3% (11/26) (P = 0.388) of proximal ileal lesions, and 80.8% (21/26) and 53.8% (14/26) (P = 0.039) of terminal ileal lesions, respectively. According to the Montreal classification, MRE and CE independently detected proximal disease (L4) in 30.8% (8/26) and 53.8% (14/26) (P = 0.092), respectively. CONCLUSIONS: The diagnostic yields of MRE and CE for the assessment of SB CD including proximal SB lesions were similar. MRE is a more objective tool for detecting clinically relevant stricture than PC although PC examination could be performed safely before CE to prove the patency of SB. This trial is registered with KCT0004305.

4.
Skeletal Radiol ; 49(2): 263-271, 2020 Feb.
Article de Anglais | MEDLINE | ID: mdl-31338533

RÉSUMÉ

OBJECTIVE: To reveal the best-suited method for fat quantification of lumbar multifidus to demonstrate its relationship to herniated nucleus pulposus (HNP) using T2-weighted Dixon. MATERIALS AND METHODS: One hundred eight patients who underwent MRI for low back pain were enrolled. Two readers independently analyzed the fat fraction (Ff) using axial two-dimensional (D), coronal 2-D, and coronal 3-D measurement. Pearson's correlation coefficient was calculated between age, body mass index (BMI), and the Ff, and age, sex, BMI, and Ff were compared between 'HNP group' and 'no HNP group'. Multivariate logistic regression analysis was performed to identify factors associated with HNP. RESULTS: Coronal 2-D Ff showed the highest correlation with age (r = 0.536, P < 0.001). Coronal 2-D Ff, and coronal 3-D Ff were significantly higher in those with HNP (coronal 2-D: 18.9 ± 2.9, coronal 3-D: 19.7 ± 2.6, respectively) than those without HNP (coronal 2-D: 17.2 ± 3.2, coronal 3-D: 17.4 ± 3.2, respectively). Ff of all three measurements were significantly higher in those with HNP ≥ 3 levels (axial 2-D: 20.7 ± 3.0, coronal 2-D: 21.1 ± 2.7, coronal 3-D: 21.6 ± 2.5, respectively) than those with HNP <3 levels (axial 2-D: 17.5 ± 4.3, coronal 2-D: 18.5 ± 2.7, coronal 3-D: 19.3 ± 2.5). The BMI was an independent predisposing factor to HNP (P = 0.011). Age and coronal 2-D Ff were significant predictors for multilevel HNP (P = 0.028 and 0.040, respectively). CONCLUSIONS: The Ff of the multifidus muscle on T2-weighted Dixon was associated with age, sex, and HNP. The coronal 2-D measurement was the best suited for fat quantification in multifidus muscle among three measurement methods.


Sujet(s)
Tissu adipeux/imagerie diagnostique , Déplacement de disque intervertébral/imagerie diagnostique , Imagerie par résonance magnétique/méthodes , Nucleus pulposus/imagerie diagnostique , Muscles paravertébraux/imagerie diagnostique , Adolescent , Adulte , Sujet âgé , Enfant , Femelle , Humains , Déplacement de disque intervertébral/anatomopathologie , Mâle , Adulte d'âge moyen , Nucleus pulposus/anatomopathologie , Études rétrospectives , Jeune adulte
5.
J Magn Reson Imaging ; 46(6): 1656-1663, 2017 12.
Article de Anglais | MEDLINE | ID: mdl-28334490

RÉSUMÉ

PURPOSE: To determine whether an oral effervescent agent improves magnetic resonance cholangiography (MRC) images, both qualitatively and quantitatively, in potential live liver donors. MATERIALS AND METHODS: This retrospective study was approved by the Institutional Review Board, and informed consent was waived. Seventy potential liver donors underwent 2D MRC before and after administration of an oral effervescent agent. One radiologist measured relative contrast ratio (rC) and relative signal intensity (rS) for right and left intrahepatic ducts (RHD and LHD), and common hepatic duct (CHD). After assessment of overall image quality, two other radiologists independently scored visualization of five ductal segments (RHD, LHD, CHD, cystic, and common bile duct) and assessed the preferred image set. In consensus, they assessed the biliary anatomy. The data were analyzed using a paired t-test, Wilcoxon's signed-rank test, and chi-square test. RESULTS: Both rC and rS of RHD and CHD were significantly higher on MRC images after administration of an oral effervescent agent than before (P < 0.03). The overall image quality grades and biliary visualization scores for all five duct segments were significantly higher on MRC images after administration of an oral effervescent agent than before (P < 0.0001). Between these images, both readers more often preferred MRC images with an effervescent agent rather than those without this agent (reader 1: 56/70, 80.0%; reader 2: 55/70, 78.6%; P = 0.0003). The readers correctly assessed second-order biliary tract anatomy in two more subjects on MRC after administration of an effervescent agent than before. CONCLUSION: Oral administration of an effervescent agent improves MRC images, both qualitatively and quantitatively, in live liver donors. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2017;46:1656-1663.


Sujet(s)
Voies biliaires/anatomie et histologie , Cholangiographie/méthodes , Produits de contraste/administration et posologie , Amélioration d'image/méthodes , Donneur vivant , Imagerie par résonance magnétique/méthodes , Administration par voie orale , Adolescent , Adulte , Études d'évaluation comme sujet , Femelle , Humains , Foie/anatomie et histologie , Transplantation hépatique , Mâle , Adulte d'âge moyen , Études rétrospectives , Jeune adulte
6.
Med Ultrason ; 18(4): 431-437, 2016 Dec 05.
Article de Anglais | MEDLINE | ID: mdl-27981274

RÉSUMÉ

AIMS: To compare the accuracy of the ultrasound attenuation index (USAI) and hepato-renal index (HRI) for the diagnosis of hepatic steatosis (HS). MATERIAL AND METHODS: Two hundred and twenty-four potential living hepatic donors underwent US and subsequent US-guided liver biopsy. The USAI was calculated from US images with an 8 MHz transducer and HRI was measured on sagittal images with a clear visualization of both the liver and kidney. Using histological degrees of HS as the reference standard, we compared the performance of USAI and HRI for diagnosing HS ≥ 5% and ≥ 30% by receiver operating characteristic curve analysis. The interobserver agreement was evaluated by using intraclass correlation coefficients (ICCs) or Bland-Altman statistics. RESULTS: Histologic degree of HS was 0-70% (median, 5%). HRI showed a tendency towards higher accuracy than USAI for diagnosing HS ≥ 5% (the area under the ROC curve, 0.856 vs. 0.820; p= 0.279) and ≥ 30% (0.937 vs. 0.909; p = 0.378) without statistical significance. There was an excellent interobserver agreement for both USAI and HRI (ICC = 0.931 and 0.973, respectively). According to the Bland-Altman method, the 95% limits of difference between two readers for HS were -8.5% to 6.6% by USAI and -4.8% to 6.2% by HRI. Most patients would have the difference of calculated HS by USAI (74.0%) and HRI (96.0%) from different operators within a range of ±5%. CONCLUSIONS: Although statistically insignificant, HRI was superior to USAI for the diagnosis and quantitative estimation of HS in terms of diagnostic performance, including accuracy and reproducibility.


Sujet(s)
Interprétation d'images assistée par ordinateur/méthodes , Rein/imagerie diagnostique , Foie/imagerie diagnostique , Stéatose hépatique non alcoolique/imagerie diagnostique , Stéatose hépatique non alcoolique/physiopathologie , Échographie/méthodes , Adolescent , Adulte , Femelle , Humains , Tests de la fonction hépatique/méthodes , Mâle , Adulte d'âge moyen , Reproductibilité des résultats , Sensibilité et spécificité , Jeune adulte
7.
J Agric Food Chem ; 64(38): 7127-33, 2016 Sep 28.
Article de Anglais | MEDLINE | ID: mdl-27573716

RÉSUMÉ

Collagen-derived small peptides, such as Gly-Pro-Hyp (GPH) and Pro-Hyp (PH), play a role in various physiological functions. Although collagen degrades in the gastrointestinal tract randomly and easily, it is not readily cleaved into bioactive peptides. To increase the bioavailability of bioactive peptides, a collagen tripeptide (CTP) was prepared from fish scales by the digestion method using collagenase from nonpathogenic Bacillus bacteria. It was demonstrated that Hyp-containing peptides-GPH and PH-were better absorbed and reached higher plasma levels after the oral administration of CTPs in rats compared to high molecular weight collagen peptide (H-CP). GPH and PH were stable in gastrointestinal fluid and rat plasma for 2 h, and GPH was able to be transported across the intestinal cell monolayer. These results suggest that the ingestion of CTP is an efficient method for taking bioactive peptides orally due to the enzymatic stability and intestinal permeability of GPH and PH.


Sujet(s)
Collagène/administration et posologie , Absorption intestinale/effets des médicaments et des substances chimiques , Oligopeptides/pharmacocinétique , Peptides/administration et posologie , Animaux , Bacillus/enzymologie , Biodisponibilité , Cellules Caco-2 , Collagène/sang , Collagène/pharmacocinétique , Collagenases/métabolisme , Stabilité enzymatique , Humains , Muqueuse intestinale/métabolisme , Intestins/effets des médicaments et des substances chimiques , Mâle , Masse moléculaire , Oligopeptides/sang , Peptides/sang , Peptides/pharmacocinétique , Perméabilité , Rats , Rat Sprague-Dawley
8.
Blood Purif ; 42(1): 83-90, 2016.
Article de Anglais | MEDLINE | ID: mdl-27189339

RÉSUMÉ

BACKGROUND/AIMS: This study aims to evaluate potential safety events and vital sign changes during active mobilization physical therapy (PT) in critically ill patients undergoing continuous renal replacement therapy (CRRT). METHODS: A retrospective review was performed on 29 patients who were treated with CRRT and who underwent 81 PT sessions in a medical intensive care unit at a single referral hospital; 15 patients underwent 33 sessions with passive range of motion (PROM) and 17 patients underwent 48 active mobilization PT sessions. Three patients received both types of PT including 8 PROM and 5 active mobilization PT sessions. The occurrences of safety events and vital sign changes during active mobilization PT sessions were evaluated. RESULTS: The safety events did not develop during 33 sessions with PROM. However, there were 2 safety events (4.1%) during 48 active mobilization PT sessions including one session with mobilization in the bed and the other in a sitting position on the edge of the bed. These safety events exclusively developed during active mobilization PT sessions, in which concomitant extracorporeal membrane oxygenation (ECMO) support and CRRT were delivered. Regarding vital sign changes during PT sessions, there were no significant differences in systolic blood pressure (BP), diastolic BP, mean arterial pressure, heart rate, respiratory rate, or peripheral oxygen saturation before and after both PROM and active mobilization PT sessions. CONCLUSIONS: This study showed that active mobilization PT can be performed safely in patients who are being treated with CRRT without a significant hemodynamic change. However, the development of potential safety events in patients with ECMO needs to be monitored carefully.


Sujet(s)
Hémodynamique , Techniques de physiothérapie , Traitement substitutif de l'insuffisance rénale , Signes vitaux , Sujet âgé , Maladie grave/thérapie , Oxygénation extracorporelle sur oxygénateur à membrane , Humains , Unités de soins intensifs , Adulte d'âge moyen , Sécurité des patients , Études rétrospectives
9.
Mol Med Rep ; 13(4): 3619-26, 2016 Apr.
Article de Anglais | MEDLINE | ID: mdl-26934832

RÉSUMÉ

Fibroblast growth factor (FGF)21 functions in the maintenance of glucose homeostasis and exerts protective effects on the liver, heat and kidneys. However, the roles of FGF21 in other tissue types are yet to be fully elucidated. The present study detected elevated expression levels of FGF21 in skin tissue. Furthermore, it was revealed that FGF21 expression in the skin was induced upon wounding. In addition, ß­klotho expression was detected in the skin tissue. To examine the role of FGF21 in the wound healing process, recombinant human (h)FGF21 was expressed in a the yeast strain Pichia (P.) pastoris, a well­known system for recombinant protein production. Based on the sequence of hFGF21 and the optimal codon of P. pastoris, codon­optimized FGF21 open reading frame sequences were obtained using seven pairs of 55­59­nt primers with seven rounds of PCR. The recombinant FGF21 was purified and its function was examined in human fibroblast cells using a wound healing cell migration assay. Treatment with FGF21 promoted cell migration, which is an important step in wound healing. Furthermore, FGF21 treatment enhanced the activity of c­Jun N­terminal kinase, a key regulator in fibroblast­cell migration. In conclusion, FGF21 is induced after wounding and FGF21 expressed and purified from yeast markedly accelerates wound healing. The present study was the first to elucidate the function of FGF21 in skin tissues and provided a theoretical basis for the use of FGF21 in the treatment of skin wounds.


Sujet(s)
Facteurs de croissance fibroblastique/métabolisme , Pichia/métabolisme , Animaux , Technique de Western , Mouvement cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Facteurs de croissance fibroblastique/génétique , Facteurs de croissance fibroblastique/pharmacologie , Fibroblastes/cytologie , Fibroblastes/métabolisme , Humains , JNK Mitogen-Activated Protein Kinases/métabolisme , Mâle , Souris , Souris de lignée C57BL , Réaction de polymérisation en chaine en temps réel , Protéines recombinantes/biosynthèse , Protéines recombinantes/isolement et purification , Protéines recombinantes/pharmacologie , Peau/métabolisme , Peau/anatomopathologie , Cicatrisation de plaie/effets des médicaments et des substances chimiques
10.
Medicine (Baltimore) ; 95(6): e2818, 2016 Feb.
Article de Anglais | MEDLINE | ID: mdl-26871854

RÉSUMÉ

The aim of the study was to examine the clinical characteristics and prognosis according to severity of thrombocytopenia and response to treatment for thrombocytopenia in patients with systemic lupus erythematosus (SLE).We retrospectively evaluated 230 SLE patients with thrombocytopenia, and reviewed their clinical data and laboratory findings. Thrombocytopenia was defined as platelet counts under 100,000/mm, and patients were divided into 3 thrombocytopenia groups according to severity: mild (platelet counts >50,000/mm), moderate (>20,000/mm, ≤50,000/mm), and severe (≤20,000/mm). Clinical characteristics, treatments, and prognoses were compared among the groups. Furthermore, complete remission of thrombocytopenia was defined as platelet counts >100,000/mm after treatment.There was no significant difference in clinical or laboratory findings among the groups according to severity of thrombocytopenia. However, hemorrhagic complications were more frequent in severe thrombocytopenia (P < 0.001) and mortality was also higher (P = 0.001). Complete remission was achieved in 85.2% of patients. The clinical characteristics and modality of treatment did not differ between the patients with and without complete remission. Mortality in patients with complete remission (1.5%) was significantly lower than in those without complete remission (29.4%, P < 0.001). Survival was significantly higher in patients with complete remission from thrombocytopenia (odds ratio = 0.049, 95% confidence interval: 0.013-0.191, P < 0.001).The severity of thrombocytopenia in SLE patients can be a useful independent prognostic factor to predict survival. Moreover, complete remission of thrombocytopenia after treatment is an important prognostic factor. The severity of thrombocytopenia and response to treatment should be closely monitored to predict prognosis in SLE patients.


Sujet(s)
Lupus érythémateux disséminé/complications , Thrombopénie/étiologie , Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Pronostic , Induction de rémission , Études rétrospectives , Indice de gravité de la maladie , Thrombopénie/diagnostic , Thrombopénie/thérapie
11.
Gut Liver ; 10(1): 133-9, 2016 Jan.
Article de Anglais | MEDLINE | ID: mdl-26260756

RÉSUMÉ

BACKGROUND/AIMS: Gallbladder polyps (GBP) are a common clinical finding and may possess malignant potential. We conducted this study to determine whether visceral obesity is a risk factor for GBP. METHODS: We retrospectively reviewed records of subjects who received both ultrasonography and computed tomography with measurements of the areas of visceral adipose tissue and total adipose tissue (TAT) on the same day as health checkups. RESULTS: Ninety-three of 1,615 subjects (5.8%) had GBP and were compared with 186 age- and sex-matched controls. VAT (odds ratio [OR], 2.941; 95% confidence interval [CI], 1.325 to 6.529; p=0.008 for the highest quartile vs. the lowest quartile) and TAT (OR, 3.568; 95% CI, 1.625 to 7.833; p=0.002 for the highest quartile vs. the lowest quartile) were independent risk factors together with hypertension (OR, 2.512; 95% CI, 1.381 to 4.569; p=0.003), diabetes mellitus (OR, 2.942; 95% CI, 1.061 to 8.158; p=0.038), hepatitis B virus positivity (OR, 3.548; 95% CI, 1.295 to 9.716; p=0.014), and a higher level of total cholesterol (OR, 2.232; 95% CI, 1.043 to 4.778; p=0.039 for. CONCLUSIONS: Visceral obesity measured by VAT and TAT was associated with GBP irrespective of body mass index or waist circumference.


Sujet(s)
Maladies de la vésicule biliaire/étiologie , Obésité abdominale/complications , Polypes/étiologie , Tissu adipeux/imagerie diagnostique , Adulte , Études cas-témoins , Cholestérol/sang , Complications du diabète , Femelle , Maladies de la vésicule biliaire/sang , Maladies de la vésicule biliaire/épidémiologie , Hépatite B/complications , Humains , Hypertension artérielle/complications , Graisse intra-abdominale/imagerie diagnostique , Mâle , Adulte d'âge moyen , Obésité abdominale/sang , Obésité abdominale/imagerie diagnostique , Odds ratio , Polypes/sang , Polypes/épidémiologie , Prévalence , Études rétrospectives , Facteurs de risque , Échographie
12.
J Vasc Interv Radiol ; 26(12): 1797-1802, 2015 Dec.
Article de Anglais | MEDLINE | ID: mdl-26603498

RÉSUMÉ

PURPOSE: To evaluate the safety and efficacy of radiofrequency (RF) ablation for hepatic metastases from gastrointestinal stromal tumor (GIST). MATERIALS AND METHODS: Retrospective review of a prospectively maintained database was performed between February 2002 and November 2010 and identified 29 patients with GISTs (18 male; age range, 35­77 y; median age, 61 y) who had undergone ultrasound-guided RF ablation for metastases detected in the liver. All patients had been treated with imatinib mesylate. Indications for RF ablation were tumor progression during medical therapy or the development of drug resistance after initial tumor control. The average number of target lesions per procedure was 2.3 (range, 1­8), and mean lesion diameter was 1.3 cm (range, 0.4­3.6 cm). RESULTS: For 69 lesions among 86 hepatic metastases, RF ablation was successfully performed according to the protocol currently in use. In 17 hepatic metastases in 13 patients, RF ablation was not performed because of poor lesion visibility or possible thermal damage to adjacent organs. Major complications included bleeding at the ablation site in one patient and peritoneal seeding near the ablation tract in another patient. Technical effectiveness was achieved for 66 of 69 lesions (95.6%). The median follow-up period was 33.1 months (range, 12.3­108.6 mo). Four of 66 lesions (6%) showed local recurrence at 3.2­10.5 months. Four patients died of disease progression. The median overall survival period was 90.2 months (range, 12.3­108.6 mo). CONCLUSIONS: RF ablation appears to be a safe and effective treatment for hepatic metastases of GIST when medical therapy fails.


Sujet(s)
Ablation par cathéter/effets indésirables , Tumeurs gastro-intestinales/chirurgie , Tumeurs stromales gastro-intestinales/chirurgie , Tumeurs du foie/secondaire , Tumeurs du foie/chirurgie , Complications postopératoires/étiologie , Adulte , Sujet âgé , Ablation par cathéter/méthodes , Femelle , Humains , Mâle , Adulte d'âge moyen , Études rétrospectives , Résultat thérapeutique
13.
Diabetes Metab J ; 39(4): 307-15, 2015 Aug.
Article de Anglais | MEDLINE | ID: mdl-26301192

RÉSUMÉ

BACKGROUND: In Korea, the prevalence, complications, and mortality rate of diabetes are rapidly increasing. However, investigations on the actual condition of diabetes management are very limited due to lack of nation-wide research or multicenter study. Hence, we have minutely inquired the current status of diabetes management and achievement of glucose target goal in general hospital offering education program. That way, we are able to furnish data for policy making of diabetes education and draw up guideline which may allow us to reduce the morbidity and mortality of diabetes. METHODS: The subjects consisted of 2,610 patients with type 2 diabetes who visited the 13 general hospital in Seoul or Gyeonggi region from March 19 to May 29, 2013. General characteristics, associated diseases, complications, and management status were investigated. RESULTS: The mean age was 61.0±11.6 years, body mass index was 25.0±3.3 kg/m(2), and family history of diabetes was 50.5%. The mean duration of diabetes was 10.7±7.9 years and 53% received education about diabetes. The prevalence of hypertension and dyslipidemia were 59.2% and 65.5%, respectively, and 18.3% of the subjects were accompanied by liver disease. Diabetic retinopathy appeared in 31.6%, nephropathy in 28.1%, and neuropathy in 19.9% of the subjects. The mean glycosylated hemoglobin (HbA1c) level was 7.3%±1.3% and the achieving rate based on Korean Diabetes Association guideline (HbA1c <6.5%) was 24.8%, blood pressure (130/80 mm Hg or less) was 49.4%, and low density lipoprotein cholesterol (<100 mg/dL) was 63.6%. The reaching rate to the target level in four parameters (blood glucose, blood pressure, lipids, and body weight) was 7.8%. CONCLUSION: The blood glucose control rate was lower than other parameters, and the implementation rate of diabetes education was only 53%. Thus more appropriate glucose control and systematic diabetes education are imperative.

14.
Respiration ; 90(3): 199-205, 2015.
Article de Anglais | MEDLINE | ID: mdl-26278777

RÉSUMÉ

BACKGROUND: Cardiovascular disease is the most common cause of death in chronic obstructive pulmonary disease (COPD). However, the impact of cardiovascular comorbidities on the prognosis of COPD is not well known. OBJECTIVES: This study was performed to investigate the effects of cardiovascular comorbidities on the prognosis of COPD. METHODS: We enlisted 229 patients with COPD who underwent comprehensive cardiac evaluations including coronary angiography and echocardiography at Ajou University Hospital between January 2000 and December 2012. Survival analyses were performed in this retrospective cohort. RESULTS: Kaplan-Meier analyses showed that COPD patients without left heart failure (mean survival = 12.5 ± 0.7 years) survived longer than COPD patients with left heart failure (mean survival = 6.7 ± 1.4 years; p = 0.003), and the survival period of nonanemic COPD patients (mean survival = 13.8 ± 0.8 years) was longer than that of anemic COPD patients (mean survival = 8.3 ± 0.8 years; p < 0.001). The survival period in COPD with coronary artery disease (CAD; mean survival = 11.37 ± 0.64 years) was not different from that in COPD without CAD (mean survival = 11.98 ± 0.98 years; p = 0.703). According to a multivariate Cox regression model, a lower hemoglobin level, a lower left ventricular ejection fraction, and the forced expiratory volume in 1 s (FEV1) were independently associated with higher mortality in the total COPD group (p < 0.05). CONCLUSIONS: Hemoglobin levels and left ventricular ejection fraction along with a lower FEV1 were identified as independent risk factors for mortality in COPD patients who underwent comprehensive cardiac evaluations, suggesting that multidisciplinary approaches are required in the care of COPD.


Sujet(s)
Maladies cardiovasculaires/diagnostic , Maladies cardiovasculaires/épidémiologie , Cause de décès , Broncho-pneumopathie chronique obstructive/épidémiologie , Sujet âgé , Analyse de variance , Maladies cardiovasculaires/mortalité , Études de cohortes , Comorbidité , Coronarographie/méthodes , Échocardiographie-doppler , Femelle , Hôpitaux universitaires , Humains , Incidence , Estimation de Kaplan-Meier , Mâle , Adulte d'âge moyen , Modèles des risques proportionnels , Broncho-pneumopathie chronique obstructive/diagnostic , Broncho-pneumopathie chronique obstructive/mortalité , Broncho-pneumopathie chronique obstructive/thérapie , République de Corée , Tests de la fonction respiratoire , Études rétrospectives , Facteurs de risque , Indice de gravité de la maladie , Analyse de survie
15.
Korean J Urol ; 56(1): 56-62, 2015 Jan.
Article de Anglais | MEDLINE | ID: mdl-25598937

RÉSUMÉ

PURPOSE: The objective was to determine whether stone density on plain radiography (kidney-ureter-bladder, KUB) could predict the outcome of extracorporeal shockwave lithotripsy (ESWL) for ureteral stones. MATERIALS AND METHODS: A total of 223 patients treated by ESWL for radio-opaque ureteral stones of 5 to 20 mm were included in this retrospective study. All patients underwent routine blood and urine analyses, plain radiography (KUB), and noncontrast computed tomography (NCCT) before ESWL. Demographic, stone, and radiological characteristics on KUB and NCCT were analyzed. The patients were categorized into two groups: lower-density (LD) group (radiodensity less than or equal to that of the 12th rib, n=163) and higher-density (HD) group (radiodensity greater than that of the 12th rib, n=60). Stone-free status was assessed by KUB every week after ESWL. A successful outcome was defined as stone free within 1 month after ESWL. RESULTS: Mean stone size in the LD group was significantly smaller than that in the HD group (7.5±1.4 mm compared with 9.9±2.9 mm, p=0.002). The overall success rates in the LD and HD groups were 82.1% and 60.0%, respectively (p=0.007). The mean duration of stone-free status and average number of SWL sessions required for success in the two groups were 21.7 compared with 39.2 days and 1.8 compared with 2.3, respectively (p<0.05). On multivariate logistic analysis, stone size and time to ESWL since colic and radiodensity of the stone on KUB were independent predictors of successful ESWL. CONCLUSIONS: Our data suggest that larger stone size, longer time to ESWL, and ureteral stones with a radiodensity greater than that of the 12th rib may be at a relatively higher risk of ESWL failure 1 month after the procedure.


Sujet(s)
Lithotritie , Calculs urétéraux/imagerie diagnostique , Calculs urétéraux/thérapie , Adulte , Sujet âgé , Colique , Femelle , Humains , Mâle , Adulte d'âge moyen , Analyse multifactorielle , Études rétrospectives , Tomodensitométrie , Résultat thérapeutique
16.
Biotechnol Lett ; 36(10): 2085-94, 2014 Oct.
Article de Anglais | MEDLINE | ID: mdl-24930114

RÉSUMÉ

Bioinformatic analysis of the genome of the methylotrophic yeast Hansenula polymorpha revealed 39 putative glycosylphosphatidylinositol-anchored proteins (GPI-proteins). Notably, dibasic motifs in the proximal ω-site, that has been reported as a plasma membrane retention signal in Saccharomyces cerevisiae GPI-proteins, were not found in any of the predicted GPI-proteins of H. polymorpha. To evaluate the in silico prediction, C-terminal peptides of 40 amino acids derived from ten H. polymorpha GPI-proteins were fused to the Aspergillus saitoi α-1,2-mannosidase (msdS). Cell wall fraction analysis showed that nine of the ten msdS-GPI fusion proteins were mostly localized at the cell wall. Surface expression of functional msdS was further confirmed by in vitro enzyme activity assay and by glycan structure analysis of cell wall mannoproteins. The recombinant H. polymorpha strains expressing surface-displayed msdS have the potential as useful hosts to produce glycoproteins with decreased mannosylation.


Sujet(s)
Paroi cellulaire/métabolisme , Protéines fongiques/isolement et purification , Pichia/métabolisme , Sites de fixation , Clonage moléculaire , Protéines fongiques/composition chimique , Protéines fongiques/génétique , Protéines fongiques/métabolisme , Glycosylphosphatidylinositols/métabolisme , Glycoprotéines membranaires/composition chimique , Glycoprotéines membranaires/génétique , Glycoprotéines membranaires/isolement et purification , Pichia/composition chimique , Pichia/cytologie , Protéines de fusion recombinantes/génétique , Protéines de fusion recombinantes/isolement et purification , Protéines de fusion recombinantes/métabolisme , alpha-Mannosidase/métabolisme
17.
Photodiagnosis Photodyn Ther ; 10(4): 694-702, 2013 Dec.
Article de Anglais | MEDLINE | ID: mdl-24284129

RÉSUMÉ

We investigated the effects of photodynamic therapy (PDT) on anti-tuberculosis (TB) activity by measuring inactivation rates, expressed as D-value, of MDR- and XDR-Mycobacterium tuberculosis (M. tb) clinical strains in vitro. Approximately 10(6) colony forming unit per milliliter (CFU/ml) of the bacilli were irradiated with various doses of laser light after exposure to photosensitizers. Survival of M. tb was measured by enumerating CFU in 7H10 medium to measure D-values. No inactivation of M. tb was observed when exposed to photosensitizers (radachlorin or DH-I-180-3) only or laser light only (P>0.1). Treatment with a combination of photosentizer and laser inactivated M. tb although there was a significant difference between the types of photosensitizers applied (P<0.05). Linear inactivation curves for the clinical M. tb strains were obtained up to laser doses of 30 J/cm(2) but prolonged irradiation did not linearly inactivate M. tb, yielding sigmoid PDT inactivation curves. D-values of M. tb determined from the slope of linear regression lines in PDT were not significantly different and ranged from 10.50 to 12.13 J/cm(2) with 670 nm laser irradiation at 100 mW/cm(2) of the fluency rate, except for a drug-susceptible strain among the clinical strains tested. This suggests that PDT inactivated M. tb clinical strains regardless of drug resistance levels of the bacilli. Intermittent and repeated PDT allowed acceleration of the inactivation of the bacilli as a way to avoid the sigmoid inactivation curves. In conclusion, PDT could be alternative as a new option for treatment for MDR- and XDR-tuberculosis.


Sujet(s)
Multirésistance bactérienne aux médicaments/effets des médicaments et des substances chimiques , Multirésistance bactérienne aux médicaments/effets des radiations , Mycobacterium tuberculosis/effets des médicaments et des substances chimiques , Photothérapie dynamique/méthodes , Porphyrines/administration et posologie , Apoptose/effets des médicaments et des substances chimiques , Apoptose/effets des radiations , Chlorophylle/analogues et dérivés , Relation dose-effet des médicaments , Relation dose-effet des rayonnements , Multirésistance bactérienne aux médicaments/physiologie , Mycobacterium tuberculosis/physiologie , Mycobacterium tuberculosis/effets des radiations , Photosensibilisants/administration et posologie , Résultat thérapeutique
18.
Korean J Urol ; 53(12): 853-9, 2012 Dec.
Article de Anglais | MEDLINE | ID: mdl-23301130

RÉSUMÉ

PURPOSE: To compare efficacy and safety between early extracorporeal shock wave lithotripsy (eESWL) and deferred ESWL (dESWL) in colic patients with ureteral stones and to investigate whether eESWL can play a critical role in improving treatment outcomes. MATERIALS AND METHODS: A total of 279 patients who underwent ESWL for single radio-opaque ureteral stones of 5 to 20 mm in size were included in this retrospective study. The patients were categorized into two groups according to the time between the onset of colic and ESWL: eESWL (<48 hours, n=153) and dESWL (≥48 hours, n=126). Success was defined as stone-free status as shown on a plain radiograph within 1 month of the first session. RESULTS: For all patients, the success rate in the eESWL group was significantly higher than that in the dESWL group. The eESWL group required significantly fewer ESWL sessions and less time to achieve stone-free status than did the dESWL group. For 241 patients with stones <10 mm, all treatment outcomes in the former group were superior to those in the latter group, but not for 38 patients with stones sized 10 to 20 mm. The superiority of eESWL over dESWL in the treatment outcomes was more pronounced for proximal ureteral stones than for mid-to-distal ureteral stones. Post-ESWL complication rates were comparable between the two groups. In the multivariate analysis, smaller stone size and a time to ESWL of <48 hours were independent predictors of success. CONCLUSIONS: Our data suggest that eESWL in colic patients with ureteral stones is an effective and safe treatment with accelerated stone clearance.

19.
Lab Chip ; 10(20): 2764-70, 2010 Oct 21.
Article de Anglais | MEDLINE | ID: mdl-20820486

RÉSUMÉ

This paper presents a high-speed RNA microextractor for the direct isolation of RNA from peripheral blood lysate using magnetic oligo-dT beads. The extraction is achieved through lateral magnetophoresis, generated by a ferromagnetic wire array inlaid on a glass substrate. This RNA microextractor separated more than 80% of magnetic beads with a flow rate up to 20 ml h(-1), and the overall extraction procedure was completed within 1 min. The absorbance ratio of RNA to protein (A(260)/A(280)) was >1.7, indicating that the extraction technology yielded nearly pure RNA. The feasibility of this technique was evaluated further for its applicability to reverse transcription polymerase chain reaction (RT-PCR) procedures by performing cDNA synthesis and PCR. The analysis verified that the RNA microextractor is a practical method for easy, rapid, and high-precision RT-PCR using minimal reagent volumes without requiring highly trained personnel. In addition, it can be readily incorporated into genetic analysis procedures for realizing automated on-chip genetic platforms in a micro format.


Sujet(s)
Biotechnologie/instrumentation , Analyse chimique du sang/instrumentation , Électrophorèse/instrumentation , Magnétisme/instrumentation , Techniques d'analyse microfluidique/instrumentation , Micromanipulation/instrumentation , Oligodésoxyribonucléotides/composition chimique , ARN/sang , Conception d'appareillage , Analyse de panne d'appareillage , Humains , ARN/composition chimique
20.
Mycobiology ; 38(1): 39-45, 2010 Mar.
Article de Anglais | MEDLINE | ID: mdl-23956623

RÉSUMÉ

White rot, which is caused by Sclerotium cepivorum, is a lethal disease affecting green onions. Three different types of nano-silver liquid (WA-CV-WA13B, WA-AT-WB13R, and WA-PR-WB13R) were tested in several different concentrations on three types of media to assess their antifungal activities. Results from in vitro experiments showed that all three of the nano-silver liquids had more than 90% inhibition rates at a concentration of 7 ppm. Greenhouse experiments revealed that all of the nano-silver liquids increased biomass and dry weights, and there were minimal changes in the population of various bacteria and fungi from the soil of greenhouse-cultivated green onions. In addition, a soil chemical analysis showed that there were minimal changes in soil composition.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...